Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis
NCT04384458
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
400
Enrollment
OTHER
Sponsor class
Conditions
Coronavirus Infections
Interventions
DRUG:
Hydroxychloroquine
DRUG:
Ivermectin
Sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara